Results 1 to 10 of about 9,036 (151)

Estimated prevalence of unregistered and falsified medicinal products in Malaysia: a nationwide cross-sectional study conducted from March to November 2023 [PDF]

Journal of Pharmaceutical Policy and Practice
Background The global proliferation of unregistered and falsified medicinal products poses significant public health risks. In Malaysia, previous studies have shown concerning prevalence rates but are often limited to specific populations and targeted ...
Khairul Anuar Abdul Karim, Asyraf Elmiza Ahmad, Mohd Zawawi Abdullah, Asniza Alias, Salina Setan, Manzatul Azrul Azrie Sulaiman, Nor Ilham ‘Ainaa Muhsin   +6 more
doaj   +2 more sources

Knowledge, attitudes and practices on substandard and falsified medicines for human and animal use in Wakiso district, Uganda [PDF]

Journal of Pharmaceutical Policy and Practice
Background Substandard and falsified medicines (SFMs) continue to pose a significant threat to public health globally. However, there is limited evidence on use of SFMs for both humans and animals particularly in low- and middle-income countries such as ...
David Musoke, Grace Biyinzika Lubega, Carol Esther Nabbanja, Filimin Niyongabo, Michael Obeng Brown, Elma Rejoice Banyen, Jody Winter, Claire Brandish, Kate Russell-Hobbs, Natasha Hamilton, Herbert Bush Aguma, Linda Gibson   +11 more
doaj   +2 more sources

Biochemical profiling provides a low-cost and globally accessible method to detect falsified vaccines and insulin [PDF]

Scientific Reports
For many decades, there have been numerous reported cases of falsified liquid medical products, including vaccine and insulin preparations worldwide, but to date, there has been a lack of affordable and accessible analytical methods for biological ...
Jennifer Brook, Tehmina Bharucha, Benediktus Yohan Arman, Céline Caillet, Susan Morris, Michelle Taylor-Siddons, Laura Gomez Fernandez, John Walsby-Tickle, Isabelle Legge, Sneha Banerjee, Michael Deats, Rajender Jena, Dnyanesh S. Ranade, Shrikrishna R. Chunekar, Kundan D. Patil, Sunil Gairola, Susanna Dunachie, Hamid A. Merchant, Robert Stokes, Rutendo Kuwana, Alexandrine Maes, Sarah Gilbert, James McCullagh, Pavel Matousek, Nicole Zitzmann, Paul N. Newton, Bevin Gangadharan, Tim James   +27 more
doaj   +2 more sources

Assessing the quality of antimalarial drugs in Equatorial Guinea: a follow-up study [PDF]

BMJ Global Health
Introduction Poor-quality antimalarial medications, including falsified and substandard formulations, pose significant public health risks, contributing to ineffective treatment and potential drug resistance.
Harparkash Kaur, Carlos A Guerra, Jeremías N Mba Eyono, Matilde Riloha Rivas, Wonder P Phiri, Guillermo A García, Laura Paris, Restituto Mba Nguema Avue, Jordan M Smith   +8 more
doaj   +2 more sources

Perception of falsified and counterfeit medicines among adults living in Mexico City and the metropolitan area: an underappreciated health risk [PDF]

Frontiers in Pharmacology
Falsified and counterfeit medicines represent a growing global public health concern and straddles business implications, and their proliferation has intensified worldwide.
Jessica Citlalli Celaya Pérez, Tania Ibargüengoitia Larios, Maria de los Angeles Frías Fernández, Manuel Abraham Gómez Martínez, Kenneth Rubio Carrasco, Kenneth Rubio Carrasco, Raúl Lugo Villegas, Arely Vergara-Castañeda   +7 more
doaj   +2 more sources

Substandard and falsified medicines in Africa: healthcare systems challenges, supply chain issues, regulatory challenges and strategies to increase access to quality medicines [PDF]

Frontiers in Pharmacology
Africa is a unique continent due to high disease burden for both communicable and non-communicable diseases, attracting large-scale distribution of medicines to tackle public health issues.
Billy Chabalenge, Tarsem Sahota, Irina Ermolina, Sangeeta Tanna   +3 more
doaj   +2 more sources

Prevalence of substandard, falsified, unlicensed and unregistered medicine and its associated factors in Africa: a systematic review

Journal of Pharmaceutical Policy and Practice
Background: Substandard, falsified, unlicensed, and unregistered medicines pose significant risks to public health in developed and developing countries. This systematic review provides an overview of the prevalence of substandard, falsified, unlicensed,
Biset Asrade Mekonnen, Minichil Worku
exaly   +3 more sources

The impact of global falsified medicines regulation on healthcare stakeholders in the legitimate pharmaceutical supply chain: a systematic review

Frontiers in Medicine
BackgroundFalsified medicines and their international regulation impacts all healthcare sectors and their actors. These regulations aim to strengthen and protect the global pharmaceutical supply chain against falsified medicines.
Bernard Naughton
exaly   +3 more sources

Medicine quality assessment in Nepal using semi randomised sampling and evaluation of a small scale dissolution test and portable Raman spectrometers [PDF]

Scientific Reports
Substandard and falsified medicines threaten global health and require reliable data and screening technologies to combat their spread. This study examined the quality of 241 samples containing azithromycin, cefixime, esomeprazole and losartan collected ...
Robin Schreiber, Md. Ahsanul Haque, Mohammad Sofiqur Rahman, Bhupendra Kumar Poudel, Balmukunda Regmi, Kazuko Kimura, Naoko Yoshida   +6 more
doaj   +2 more sources

Global perspective of the risks of falsified and counterfeit medicines: A critical review of the literature

Travel Medicine and Infectious Disease
Background: The increasing prevalence of falsified and counterfeit medicines globally poses risks to international travellers. This narrative literature review examines the global challenge of falsified and counterfeit medicines, with a specific focus on
, Gérard Flaherty
exaly   +3 more sources